Potentiation of cytotoxicity of mitoxantrone toward CHO-K1 cells in vitro by dipyridamole
- PMID: 1553337
- DOI: 10.1023/a:1018920903436
Potentiation of cytotoxicity of mitoxantrone toward CHO-K1 cells in vitro by dipyridamole
Abstract
Dipyridamole (DP), a clinically used vasodilator and an antiplatelet compound, augmented the activity of the anticancer drug mitoxantrone (MXN) toward chinese hamster ovary (CHO-K1) cells in culture. Clonogenic assays indicated that DP (1.0, 2.5, and 5.0 microM) decreased the survival of cells treated with MXN (5 to 25 nM) in a dose-dependent manner. Further, DP (1 and 5 microM) decreased the MXN concentration required for 50% inhibition of cell growth from 3.2 to 1.8 and from 3.0 to 0.5 nM, respectively, over a period of 3 days. DP (10 microM) increased the accumulation of MXN by 1.8-fold in exponentially growing cells exposed to MXN. The enhanced levels of MXN in CHO-K1 cells in the presence of the chemosensitizer may account for the potentiation of MXN-cytotoxicity by DP.
Similar articles
-
Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells.Br J Cancer. 1996 Apr;73(7):856-60. doi: 10.1038/bjc.1996.152. Br J Cancer. 1996. PMID: 8611395 Free PMC article.
-
Effect of tamoxifen on mitoxantrone cytotoxicity in drug-sensitive and multidrug-resistant MCF-7 cells.Cancer Chemother Pharmacol. 1995;36(5):368-72. doi: 10.1007/BF00686184. Cancer Chemother Pharmacol. 1995. PMID: 7634377
-
Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line.Zhongguo Yao Li Xue Bao. 1992 Sep;13(5):416-9. Zhongguo Yao Li Xue Bao. 1992. PMID: 1300043
-
Enhancement of 5-fluorouracil's anticancer activity by dipyridamole.Pharmacol Ther. 1989;40(3):349-71. doi: 10.1016/0163-7258(89)90084-3. Pharmacol Ther. 1989. PMID: 2646650 Review.
-
[Modification of Chinese hamster ovary cells].Sheng Wu Gong Cheng Xue Bao. 2002 Jul;18(4):415-9. Sheng Wu Gong Cheng Xue Bao. 2002. PMID: 12385235 Review. Chinese.
Cited by
-
Dipyridamole prevents triple-negative breast-cancer progression.Clin Exp Metastasis. 2013 Jan;30(1):47-68. doi: 10.1007/s10585-012-9506-0. Epub 2012 Jul 4. Clin Exp Metastasis. 2013. PMID: 22760522 Free PMC article.
-
Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancer.Invest New Drugs. 1994;12(4):283-7. doi: 10.1007/BF00873042. Invest New Drugs. 1994. PMID: 7775128 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources